Galia Spectre
Overview
Explore the profile of Galia Spectre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamulyak E, Wang T, Kreuziger L, Iyengar V, Carney B, Hoeben A, et al.
Haematologica
. 2025 Feb;
PMID: 39911106
Not available.
2.
Partouche S, Goldberg I, Halperin E, Atamna B, Shacham-Abulafia A, Shapira S, et al.
Int J Mol Sci
. 2025 Jan;
25(24).
PMID: 39769242
Neutrophils and neutrophil extracellular traps (NETs) contribute to thrombosis and hyperinflammation in myeloproliferative neoplasms (MPN). High-density neutrophils (HDNs) and low-density neutrophils (LDNs) have recently been characterized as distinct neutrophil sub-populations...
3.
Gurevich-Shapiro A, Orbach-Zinger S, Leader A, Stemer G, Wiznitzer A, Singer P, et al.
Res Pract Thromb Haemost
. 2024 Dec;
8(8):102579.
PMID: 39717280
Background: Postpartum hemorrhage is considered a risk factor for pregnancy-associated complement-mediated hemolytic uremic syndrome (CM-HUS; previously known as atypical hemolytic uremic syndrome) but has not been systematically studied. Objectives: To...
4.
Goldberg I, Spectre G, Raanani P, Ten Cate H, Leader A
Acta Haematol
. 2024 Dec;
1-17.
PMID: 39662064
Background: Managing cancer-associated thrombosis (CAT) is a significant clinical challenge due to several factors such as increased bleeding tendency, frailty, and drug-drug interactions. For many years, the drug of choice...
5.
Drozdinsky G, Arad N, Spectre G, Livneh N, Poran I, Raanani P, et al.
Thromb Res
. 2024 Feb;
235:92-97.
PMID: 38308884
Introduction: Atrial fibrillation or flutter (AF) is prevalent in cancer patients. Many of these patients have an indication for anticoagulation (AC) but are also at risk for developing chemotherapy-induced thrombocytopenia....
6.
Rottenstreich A, Kalish Y, Gilan A, Spectre G, Kleinstern G, Dior U
Blood Coagul Fibrinolysis
. 2023 Jul;
34(5):305-309.
PMID: 37395195
Objectives: Previous studies have suggested that endometriosis is associated with increased hypercoagulable state. We aimed to determine the procoagulant potential among women with endometriosis before and after surgery. Methods: A...
7.
Leader A, Mendelson Cohen N, Afek S, Jaschek R, Frajman A, Itzhaki Ben Zadok O, et al.
JACC CardioOncol
. 2023 May;
5(2):174-185.
PMID: 37144112
Background: It is unclear whether newly diagnosed cancer adds to the risk of arterial thromboembolism (ATE) in patients with atrial fibrillation/flutter (AF). This is especially relevant for AF patients with...
8.
Icht O, Leader A, Batat E, Yosef L, Shochat T, Goldstein D, et al.
Oncologist
. 2023 Apr;
28(6):e391-e396.
PMID: 37014824
Introduction: There is scarce data regarding the incidence of venous thromboembolism (VTE) and arterial thromboembolism (ATE) in the molecular subtypes of non-small cell lung cancer (NSCLC). We aimed to investigate...
9.
Robinson R, Spectre G, Lishner M, Sharabi O, Robinson E, Hamburger Avnery O, et al.
J Thromb Thrombolysis
. 2023 Mar;
55(4):729-736.
PMID: 36943661
Data are needed on direct oral anticoagulants (DOACs) for the treatment of venous thromboembolism (VTE) in hematological malignancies (HM). Retrospective studies to date lacked a control group and did not...
10.
Wiessman M, Kheifets M, Schamroth Pravda N, Leshem Lev D, Ziv E, Kornowski R, et al.
J Thromb Thrombolysis
. 2023 Jan;
55(3):407-414.
PMID: 36598739
Background: Thrombin generation (TG), platelet function and circulating endothelial progenitor cells (EPCs) have an important role in the pathophysiology of coronary artery disease (CAD). To date, the effect of novel...